相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting Neuropathic Pain: Pathobiology, Current Treatment and Peptidomimetics as a New Therapeutic Opportunity
Maria Cristina Caroleo et al.
CURRENT MEDICINAL CHEMISTRY (2020)
The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Antitussive Therapy for Chronic Refractory Cough Results From a Phase 2 Pilot Study (VOLCANO-1)
Jaclyn Smith et al.
CHEST (2020)
Serotonin and substance P: Synergy or competition in the control of breathing
Malgorzata Szereda-Przestaszewska et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2020)
ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19
Rhian M. Touyz et al.
CLINICAL SCIENCE (2020)
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics
Andre C. Kalil
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning
Yehuda Shoenfeld
AUTOIMMUNITY REVIEWS (2020)
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
Dennis McGonagle et al.
AUTOIMMUNITY REVIEWS (2020)
Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
Zikuan Leng et al.
AGING AND DISEASE (2020)
Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire?
Colin Casault et al.
NEUROCRITICAL CARE (2019)
Involvement of Substance P in the Analgesic Effect of Low-Level Laser Therapy in a Mouse Model of Chronic Widespread Muscle Pain
Der-Sheng Han et al.
PAIN MEDICINE (2019)
Regulation of Cardiac Mast Cell Maturation and Function by the Neurokinin-1 Receptor in the Fibrotic Heart
Alexander Widiapradja et al.
SCIENTIFIC REPORTS (2019)
Activation of mitogen-activated protein kinases in satellite glial cells of the trigeminal ganglion contributes to substance P-mediated inflammatory pain
Yanyan Zhang et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2019)
Persistently High Serum Substance P Levels and Early Mortality in Patients with Severe Traumatic Brain Injury
Leonardo Lorente et al.
WORLD NEUROSURGERY (2019)
Substance P and pain chronicity
W. Zieglgaensberger
CELL AND TISSUE RESEARCH (2019)
Emerging targets for cough therapies; NK1 receptor antagonists
Huda Badri et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2019)
Neuropeptides and breathing in health and disease
Katarzyna Kaczynska et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2018)
Neurochemical Alterations in Sudden Unexplained Perinatal Deaths-A Review
Nazeer Muhammad et al.
FRONTIERS IN PEDIATRICS (2018)
Abnormalities in substance P neurokinin-1 receptor binding in key brainstem nuclei in sudden infant death syndrome related to prematurity and sex
Fiona M. Bright et al.
PLOS ONE (2017)
Towards Better Understanding of the Pathogenesis of Neuronal Respiratory Network in Sudden Perinatal Death
Riffat Mehboob et al.
FRONTIERS IN NEUROLOGY (2017)
Substance P/Neurokinin 1 and Trigeminal System: A Possible Link to the Pathogenesis in Sudden Perinatal Deaths
Riffat Mehboob
FRONTIERS IN NEUROLOGY (2017)
Neuropeptide substance P and the immune response
Alireza Mashaghi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Role of substance P in the cardiovascular system
Eliska Mistrova et al.
NEUROPEPTIDES (2016)
Immunohistochemical Analysis of Brainstem Lesions in the Autopsy Cases with Severe Motor and Intellectual Disabilities Showing Sudden Unexplained Death
Masaharu Hayashi et al.
FRONTIERS IN NEUROLOGY (2016)
Role of neurotransmitter Substance P in progression of oral squamous cell carcinoma
Riffat Mehboob et al.
PATHOLOGY RESEARCH AND PRACTICE (2015)
Substance P Receptor Antagonism: A Potential Novel Treatment Option for Viral-Myocarditis
Prema Robinson et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Aprepitant in the Prevention of Vomiting Induced by Moderately and Highly Emetogenic Chemotherapy
Shi-Yong Wang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Inhibitors of endopeptidase and angiotensin-converting enzyme lead to an amplification of the morphological changes and an upregulation of the substance P system in a muscle overuse model
Yafeng Song et al.
BMC MUSCULOSKELETAL DISORDERS (2014)
Effects of Neutral Endopeptidase (Neprilysin) Inhibition on the Response to Other Vasoactive Peptides in Small Human Resistance Arteries: Studies with Thiorphan and Omapatrilat
Jonathan R. Dalzell et al.
CARDIOVASCULAR THERAPEUTICS (2014)
Substance P Increases Sympathetic Activity During Combined Angiotensin-Converting Enzyme and Dipeptidyl Peptidase-4 Inhibition
Jessica K. Devin et al.
HYPERTENSION (2014)
Substance P in heart failure: The good and the bad
Heather M. Dehlin et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
HIV infection of macrophages is enhanced in the presence of increased expression of CD163 induced by substance P
Florin Tuluc et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension
Heather M. Dehlin et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Involvement of substance P and the NK-1 receptor in cancer progression
Miguel Munoz et al.
PEPTIDES (2013)
Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells
Giselle C. Melendez et al.
CARDIOVASCULAR RESEARCH (2011)
Developmental alterations of the spinal trigeminal nucleus disclosed by substance P immunohistochemistry in fetal and infant sudden unexplained deaths
Anna M. Lavezzi et al.
NEUROPATHOLOGY (2011)
Hypoxia-Induced Down-Regulation of Neprilysin by Histone Modification in Mouse Primary Cortical and Hippocampal Neurons
Zheng Wang et al.
PLOS ONE (2011)
Plasma Substance P Levels in Patients with Persistent Cough
Kojiro Otsuka et al.
RESPIRATION (2011)
Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals
Mark M. Manak et al.
AIDS (2010)
Disturbed immunoregulatory properties of the neuropeptide substance P on lymphocyte proliferation in HIV infection
M. J. COVAS et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R)
Irene Chernova et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Substance p is associated with heart enlargement and apoptosis in murine dilated cardiomyopathy induced by Taenia crassiceps infection
Melinda D'Souza et al.
JOURNAL OF PARASITOLOGY (2007)
Herpes simplex virus type-1 latency-associated transcript-induced immunoreactivity of substance P in trigeminal neurons is reversed by bone morphogenetic protein-7
Mohamed A. Hamza et al.
NEUROSCIENCE LETTERS (2007)
Tachykinin receptors antagonists: From research to clinic
Laura Quartara et al.
CURRENT DRUG TARGETS (2006)
G protein-coupled receptors in haematopoietic disruption
SH Ramkissoon et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
Tachykinin-mediated modulation of the immune response
KL Bost
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Substance P and neurokinin-1 receptor modulation of HIV
WZ Ho et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
The role of substance P in inflammatory disease
TM O'Connor et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Airway hyperresponsiveness and calcium handling by smooth muscle - A deeper look
K Parameswaran et al.
CHEST (2002)
IL-4 and IFN-γ up-regulate substance P receptor expression in murine peritoneal macrophages
I Marriott et al.
JOURNAL OF IMMUNOLOGY (2000)
Respiratory actions of tachykinins in the nucleus of the solitary tract: effect of neonatal capsaicin pretreatment
SB Mazzone et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
分享论文
